Publications by authors named "V Cusnir"
A neural network model for predicting the effectiveness of treatment in patients with neovascular glaucoma associated with diabetes mellitus.
Rom J Ophthalmol
October 2024
Article Synopsis
- The study explores the effectiveness of neural networks in predicting treatment outcomes for diabetic neovascular glaucoma (NVG), focusing on intraocular pressure, inflammation, and blood circulation indicators.
- The research involves a cohort of 127 NVG patients and a control group, using specific preoperative indices to analyze the impact on treatment success after transscleral cyclophotocoagulation (TSC CPC).
- The neural network model developed highlighted the significance of the systemic inflammation response index (SIRI), rheographic coefficient (RQ), and systemic immune-inflammation index (SII) in predicting treatment efficacy, demonstrating high sensitivity but lower specificity.
The study hypothesizes that some patients with diabetic neovascular glaucoma (NVG) do not fully respond to transscleral (TSC) cyclophotocoagulation (CPC) due to significant inflammation and insufficient glucose control. The study aimed to determine the effect of baseline blood levels of intercellular adhesion molecule-1 (ICAM-1) and glycated haemoglobin (HbA1c) on the management of patients with diabetic NVG by TSC CPC. This open prospective study included 70 diabetic patients (75 eyes; aged Ме 63.
View Article and Find Full Text PDFNeovascular glaucoma (NVG) is a type of secondary glaucoma, refractory to treatment, often incurable, with very poor visual prognosis. It is characterized by the appearance of new vessels over the iris and iridocorneal angle and frequently associates the presence of a fibrovascular membrane which limits the aqueous humor outflow from the anterior chamber. The most common causes of NVG are: central retinal vein occlusion, proliferative diabetic retinopathy, and ocular ischemic syndrome.
View Article and Find Full Text PDFArticle Synopsis
- The Tear Film & Ocular Surface Society (TFOS) focuses on enhancing research and education in the tear film and ocular surface field through various initiatives and programs.
- The TFOS Global Ambassador program consists of proactive experts who promote TFOS initiatives and share findings like the TFOS DEWS II™ recommendations globally.
- A meeting in Rome in September 2019 discussed the needs and proposed solutions for managing ocular surface diseases across 25 European countries.
The dry eye syndrome (DES) is a disease of the ocular surface, which can become a social issue in our country, given the changes in lifestyle as a consequence of the economic and technological developments of the last decade. A current problem is the prevalence of DES in patients with glaucoma. The glaucoma treatment, especially the prolonged instillation of preservative-containing medicines, is an important factor in DES morbidity, especially in people aged over 40.
View Article and Find Full Text PDF